Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Re-Step: Dynamic Balance Treatment of Gait for Acquired Brain Injury (ABI) Victims

9 mars 2021 uppdaterad av: Reuth Rehabilitation Hospital

Re-Step: a Computerized Dynamic Balance Treatment for Rehabilitation of Unassisted Gait in ABI Victims: a Prospective, Exploratory and Interventional Clinical Trial

The purpose of this study is to:

  1. Test the walking functionality of people following Acquired brain injury (ABI)
  2. Suggesting a new treatment for their walking impairments
  3. Follow-up of motor learning ability and balance after intervention within this population

The investigators intend to target dynamic stability and gait after ABI, in a group of individuals with ABI who have persistent balance and mobility deficits despite being able to walk independently and having high scores on standard clinical balance measures.

Interventions: Training with Re-Step system shoes.

In this study there is no control group.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

Study design:

Type of research: Prospective, exploratory, clinical, interventional trial

Specific objectives are:

To explore the efficacy of Re-step rehabilitation technology to improve dynamic balance in the gait of people after Acquired Brain Injury (ABI).

The investigators suggest a new technology of intervention that will induce unexpected changes of underfoot slopes, with Re-Step shoes, during walking and will force the central nervous system (CNS) to react and solve walking problems in real-time.

The investigators propose that the new approach will have a significant motor function improvement on balance in gait, transferred to real environmental settings and be retained for long periods of time.

Research methods:

Subjects:

A total of 40 subjects of ABI victims will be studied in one treatment group-Re-Step shoes walking training

Time flow protocol:

Participants will be approached using a database of hospitalized patients of Reuth Rehabilitation Hospital (Tel-Aviv, Israel) and through a call for participation placed in a newspaper.

Subjects will be recruited according to inclusion/exclusion criteria, after medical examination and given consent of participation.

Tests and measures (see outcome measures) will be applied to measure changes:

  • T1 - before starting the intervention to form a baseline
  • T2 - after 20 sessions of intensive treatments 60 min each, 2 sessions a week.
  • T3 - 6 months after T2, a period of normal daily schedule of subjects, with no interventions, to examine for retainment of training results.

The treatments will start in a week from T1; the T2 will be performed in a week after training was completed; T3 will be performed 6 months (take or leave 2 weeks) after T2.

Studietyp

Interventionell

Inskrivning (Faktisk)

41

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Tel-Aviv, Israel, 6772829
        • Reuth Rehabilitation Hospital

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 80 år (Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  • At least one year after the Acquired brain injury.
  • Age 18 to 80 years
  • Independent walking ability for at least 10 meters
  • Patients who permanently use medications that have not been changed during the past month and with no further changes expected during the research
  • At least 19 points on the MoCA test

Exclusion Criteria:

  • Presence of degenerative neurological disability that is not secondary to the acquired brain injury
  • Other disabilities such as - severe back pain, radical active lumbosacral radicular pain, leg muscle pain, peripheral neuropathy, post-polio syndrome, rheumatic illnesses, previous orthopedic disabilities preceding or at the time of the injury that could affect the ability and pattern of walking, depression, and other neurotic syndromes including post-traumatic depression and post-traumatic stress disorder (PTSD) at a medium level or higher, chronic alcoholism and use of drugs.
  • Unstable state of health such as heart disease, respiratory insufficiency, peripheral vascular disease, acquired brain injury that has impaired walking ability
  • Inability to persevere and cooperate in the series of tests and the follow-up

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: N/A
  • Interventionsmodell: Enskild gruppuppgift
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Re-Step

The system consists of a pair of special shoes which sole height and angles change in a specific given order, thereby facilitating motor learning and problem solving in real time.

This unpredictable change will introduce a situation of necessary adaptation to keep balance.

Research Group:

Each session begins with a warm-up exercise, muscle stretching, and strengthening exercises: duration 10 minutes.

Afterwards, walking exercises for 40 minutes with Re-Step according to a program individually tailored and progressing with the training. Progress is shown by an increased range of tilting of the shoe and speed of changes, according to the individual ability of each patient.

At the end of the session 10 min of cool-down exercises

22 training sessions of 60 minutes each, twice a week.

Andra namn:
  • Step of Mind's Re-Step System shoes

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Community Balance & Mobility Scale (CB&M); Change from base line after intervention is being assessed
Tidsram: Measuring mobility ability and balance at base line and changes after intervention; and changes and rtainment of achievments 6 months of no intervention
CB&M was designed to evaluate balance and mobility in patients who, although ambulatory, have balance impairments that reduce their full engagement in community living. 13 items of dynamic balance are graded 0-5 by a physiotherapist. The CB&M is a reliable and valid clinical outcome measure for evaluating change in ability in the higher functioning ambulatory patients with TBI.
Measuring mobility ability and balance at base line and changes after intervention; and changes and rtainment of achievments 6 months of no intervention

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
10 Meter walk Test (10MWT)
Tidsram: Measuring at base line; change immediately after intervention, and changes and retainments of achievments after 6 months
Assesses walking speed in meters per second over a short duration. The individual is instructed to walk a set distance (6 meters, 10 meters, etc). Time is measured while the individual walks the set distance (often the individual is given space to accelerate to his/her preferred walking speed (this distance is not included when determining speed). The distance covered is divided by the time it took the individual to walk that distance.
Measuring at base line; change immediately after intervention, and changes and retainments of achievments after 6 months
Montreal Cognitive Assessment (MoCA)
Tidsram: Recruitment stage

Widely used method for assessing cognitive mental status both in clinical practice and in research.

It is a brief, standardized method to grade patients' cognitive mental status. It assesses orientation, attention, immediate and short-term recall, language, and the ability to follow simple verbal and written commands. It provides a total score that places the individual on a scale of cognitive function.

The MoCA test has a high sensitivity for detecting cognitive dysfunction.

Recruitment stage
fMRI functional magnetic Resonance Imaging; Change from base line after intervention is being assessed
Tidsram: Base line brain activity; change after treatment; and change after 6 months with no interventions
Functional magnetic resonance imaging or functional MRI (fMRI) is a functional neuroimaging procedure using MRI technology that measures brain activity by detecting associated changes in blood flow. This technique relies on the fact that cerebral blood flow and neuronal activation are coupled. When an area of the brain is in use, blood flow to that region also increases.
Base line brain activity; change after treatment; and change after 6 months with no interventions

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Simona Bar-Haim, PhD; PT, The Laboratory for Rehabilitation and Motor Control of Walking Faculty of Health Sciences at Ben-Gurion University of the Negev Israel
  • Studierektor: Jean-Jacques Vatine, Dr., Reuth Rehabilitation Hospital Tel-Aviv Israel.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart

1 september 2014

Primärt slutförande (Faktisk)

30 maj 2018

Avslutad studie (Faktisk)

30 maj 2018

Studieregistreringsdatum

Först inskickad

24 juli 2014

Först inskickad som uppfyllde QC-kriterierna

11 augusti 2014

Första postat (Uppskatta)

13 augusti 2014

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 mars 2021

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

9 mars 2021

Senast verifierad

1 mars 2021

Mer information

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Kliniska prövningar på Förvärvad hjärnskada

Kliniska prövningar på Re-Step

3
Prenumerera